Pages that link to "Q45929303"
Jump to navigation
Jump to search
The following pages link to Heidi T. May (Q45929303):
Displaying 50 items.
- Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies (Q22306352) (← links)
- Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques (Q30419529) (← links)
- Repeated measurement of the intermountain risk score enhances prognostication for mortality (Q31123541) (← links)
- Coronary artery plaque volume and obesity in patients with diabetes: the factor-64 study (Q34681052) (← links)
- HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative (Q34857996) (← links)
- Superior predictive ability for death of a basic metabolic profile risk score (Q34976518) (← links)
- Exceptional mortality prediction by risk scores from common laboratory tests (Q34984240) (← links)
- A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL₃ IDL]). (Q36843460) (← links)
- Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography (Q36949170) (← links)
- Relation of bisphosphonate therapies and risk of developing atrial fibrillation (Q37408617) (← links)
- Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial (Q38420815) (← links)
- Panoptic total cardiovascular risk prediction using all predictors versus optimized risk assessment using variable subsets (Q39546907) (← links)
- Antilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depression (Q42972547) (← links)
- Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians (Q43248610) (← links)
- Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures (Q43908385) (← links)
- Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? (Q44315758) (← links)
- Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population (Q44324240) (← links)
- Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease (Q44635700) (← links)
- Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia (Q44681950) (← links)
- Effect of work-hour restriction on operative experience in cardiothoracic surgical residency training (Q44713562) (← links)
- Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia (Q44850250) (← links)
- Clinical predictors of risk for atrial fibrillation: implications for diagnosis and monitoring (Q44982346) (← links)
- Incidence of dementia in relation to genetic variants at PITX2, ZFHX3, and ApoE ε4 in atrial fibrillation patients (Q45056836) (← links)
- Lack of association of tegaserod with adverse cardiovascular outcomes in a matched case-control study. (Q45929234) (← links)
- Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes (Q46074020) (← links)
- Randomized cross-over trial of short-term water-only fasting: metabolic and cardiovascular consequences (Q46302743) (← links)
- Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study). (Q46723852) (← links)
- Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation (Q46910098) (← links)
- Relation of routine, periodic fasting to risk of diabetes mellitus, and coronary artery disease in patients undergoing coronary angiography (Q48011292) (← links)
- Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks (Q48233485) (← links)
- Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure (Q48425390) (← links)
- Association of vitamin D levels with incident depression among a general cardiovascular population (Q49159907) (← links)
- The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints (Q50565811) (← links)
- Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry (Q50914396) (← links)
- Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide (Q50935741) (← links)
- Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease (Q50937864) (← links)
- A strategy of rapid cardioversion minimizes the significance of early recurrent atrial tachyarrhythmias after ablation for atrial fibrillation (Q51377539) (← links)
- Fasting and other health influences (Q51428111) (← links)
- Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk? (Q51483169) (← links)
- Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. (Q53107274) (← links)
- Depression after coronary artery disease is associated with heart failure. (Q53196160) (← links)
- Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy. (Q53241319) (← links)
- Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility. (Q53523280) (← links)
- The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. (Q53651822) (← links)
- Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction. (Q53655221) (← links)
- Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only. (Q54447957) (← links)
- Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genes (Q59689580) (← links)
- Intracardiac Ultrasound for Esophageal Anatomic Assessment and Localization During Left Atrial Ablation for Atrial Fibrillation (Q59689587) (← links)
- Patients Treated with Catheter Ablation for Atrial Fibrillation Have Long-Term Rates of Death, Stroke, and Dementia Similar to Patients Without Atrial Fibrillation (Q59689643) (← links)
- The intermountain risk score predicts incremental age-specific long-term survival and life expectancy (Q59689663) (← links)